Letter
Authors:
- Emmanuelle BompasEBEmmanuelle Bompas
- Olivier BoillotOBOlivier Boillot
- Pierre-Paul BringuierPBPierre-Paul Bringuier
- Jérôme DumortierJDJérôme Dumortier
- Jean-Yves BlayJBJean-Yves Blay
- 1 June 2004
- journal article
- other
- Published by Elsevier in European Journal of Cancer
- Vol. 40 (9) , 1456-1457
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571)European Journal of Cancer, 2002
- Update of phase I study of imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma GroupEuropean Journal of Cancer, 2002
- Mechanisms of Clinically Relevant Drug Interactions Associated with TacrolimusClinical Pharmacokinetics, 2002
- ImatinibDrugs, 2001
- Gastrointestinal Stromal Tumors/Smooth Muscle Tumors (GISTs) Primary in the Omentum and MesenteryAmerican Journal of Surgical Pathology, 1999